These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 6949391)

  • 21. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA class I and II antigens expression in patients with renal cell carcinoma.
    Ozgur BC; Gonenc F; Yazicioglu AH
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):97-101. PubMed ID: 19112225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary evaluation of DR antigens in responders and nonresponders to antigen D from the Rh blood group system.
    Wojtulewicz-Kurkus J; Zupańska B; Podobińska I; Brojer E
    Arch Immunol Ther Exp (Warsz); 1981; 29(4):447-50. PubMed ID: 6800338
    [No Abstract]   [Full Text] [Related]  

  • 24. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of HLA polymorphism in the 6965 Han bone marrow registry donors].
    Wu GG; Deng ZH; Gao SQ; Cheng LH; Jin SZ; Zhou D; Li Z; Zou HY; Zhang X; Wei TL; Cheng X; Wang DM
    Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):473-7. PubMed ID: 15555263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.
    Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K
    Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for Induced Expression of HLA Class II on Human Islets: Possible Mechanism for HLA Sensitization in Transplant Recipients.
    Jackson AM; Connolly JE; Matsumoto S; Noguchi H; Onaca N; Levy MF; Naziruddin B
    Transplantation; 2009 Feb; 87(4):500-6. PubMed ID: 19307785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells.
    Ranella A; Vassiliadis S; Mastora C; Valentina M; Dionyssopoulou E; Athanassakis I
    Hum Immunol; 2005 Jan; 66(1):43-55. PubMed ID: 15620461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA and disease associations with special reference to mechanisms.
    Svejgaard A; Morling N; Platz P; Ryder LP; Thomsen M
    Transplant Proc; 1981 Mar; 13(1 Pt 2):913-7. PubMed ID: 7022961
    [No Abstract]   [Full Text] [Related]  

  • 31. The HLA-DR antigen frequency in Northern Ireland compared to the frequency in Bristol, Edinburgh and Eire.
    Middleton D; Jordan J; Martin J; Spencer S
    Tissue Antigens; 1985 Apr; 25(4):220-1. PubMed ID: 3859947
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunogenetic aspects of the relationship between HLA-DR and the MB and MT system.
    Duquesnoy RJ
    Transplant Proc; 1981 Dec; 13(4):1804-7. PubMed ID: 6977217
    [No Abstract]   [Full Text] [Related]  

  • 33. Further study of the "tail portion" of antigen MT-2--an analysis of "Se-11".
    Sekiguchi S; Takata H; Konoeda Y; Ono C; Iri H
    Transplant Proc; 1981 Dec; 13(4):1991-5. PubMed ID: 6949391
    [No Abstract]   [Full Text] [Related]  

  • 34. Possible new DR antigens: Cy6.1 and its variants.
    Aoki M; Miyajima T; Matsuyama M; Higuchi R; Yokoyama T; Amemiya H
    Transplant Proc; 1981 Dec; 13(4):1989-90. PubMed ID: 6949390
    [No Abstract]   [Full Text] [Related]  

  • 35. New DR subtypes included in MT2.
    Maeda H; Juji T
    Transplant Proc; 1981 Dec; 13(4):1985-8. PubMed ID: 6949389
    [No Abstract]   [Full Text] [Related]  

  • 36. The heterogeneity of antigen DRw8.
    Nakai Y; Kasahara M; Moriuchi J; Masuda K; Wakisaka A; Aizawa M; Itakura K
    Transplant Proc; 1981 Dec; 13(4):1996-9. PubMed ID: 6977226
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.